DK48489D0 - Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse - Google Patents
Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelseInfo
- Publication number
- DK48489D0 DK48489D0 DK048489A DK48489A DK48489D0 DK 48489 D0 DK48489 D0 DK 48489D0 DK 048489 A DK048489 A DK 048489A DK 48489 A DK48489 A DK 48489A DK 48489 D0 DK48489 D0 DK 48489D0
- Authority
- DK
- Denmark
- Prior art keywords
- hetero
- beta
- preparation
- phenylgyline
- oralized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3803169A DE3803169A1 (de) | 1988-02-03 | 1988-02-03 | Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln |
Publications (2)
Publication Number | Publication Date |
---|---|
DK48489D0 true DK48489D0 (da) | 1989-02-02 |
DK48489A DK48489A (da) | 1989-08-04 |
Family
ID=6346529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK048489A DK48489A (da) | 1988-02-03 | 1989-02-02 | Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse |
Country Status (17)
Country | Link |
---|---|
US (1) | US4980348A (da) |
EP (1) | EP0326887B1 (da) |
JP (1) | JPH021488A (da) |
KR (1) | KR890013055A (da) |
CN (1) | CN1035511A (da) |
AT (1) | ATE80629T1 (da) |
AU (1) | AU616453B2 (da) |
CA (1) | CA1329198C (da) |
DD (1) | DD283329A5 (da) |
DE (2) | DE3803169A1 (da) |
DK (1) | DK48489A (da) |
FI (1) | FI890482A (da) |
HU (1) | HU204825B (da) |
IL (1) | IL89126A0 (da) |
NO (1) | NO890287L (da) |
PT (1) | PT89582B (da) |
ZA (1) | ZA89811B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5099015A (en) * | 1991-01-10 | 1992-03-24 | Eli Lilly And Company | Trifluoromethyl 1-carba(1-dethia)cephems |
JP3238209B2 (ja) * | 1992-09-30 | 2001-12-10 | 塩野義製薬株式会社 | チオメチルチオカルバセファロスポリン誘導体 |
CN103965214B (zh) * | 2014-05-28 | 2016-04-13 | 东南大学 | 一种β-内酰胺类化合物及其制备方法和应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1174335A (en) | 1967-03-07 | 1969-12-17 | Lilly Co Eli | 7-Alpha-Amino-3-Methyl Cephalosporin Analogues, Pharmaceutical Compositions comprising the same and processes for preparing the same |
US4226866A (en) * | 1972-11-06 | 1980-10-07 | Merck & Co., Inc. | Novel antibiotic analogues of cephalosporins |
YU36970B (en) | 1973-02-23 | 1984-08-31 | Lilly Co Eli | Process for obtaining 7-(amino)-acylamido-3-halocephalosporins |
IL52144A (en) | 1976-07-01 | 1979-10-31 | Lilly Co Eli | De-esterification process for -lactam antibiotic esters |
NO155547C (no) | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling. |
NO155548C (no) | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
US4255424A (en) * | 1979-04-27 | 1981-03-10 | Merck & Co., Inc. | 7-N-Heterocyclyl 1-oxa, 1-aza, and 1-carbadethiacephalosporins |
DK389080A (da) | 1979-09-13 | 1981-03-14 | Kyowa Hakko Kogyo Kk | Fremgangsmaade til fremstilling af racemiske eller optisk aktive cephalosporin-analoge carbacephemforbindelser eller farmaceutisk accepable salte deraf |
DE3069901D1 (en) | 1979-10-25 | 1985-02-14 | Kyowa Hakko Kogyo Kk | Optically active cephalosporin analogs, process for their preparation and their use |
JPS5849382A (ja) | 1981-09-18 | 1983-03-23 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
JPS5874680A (ja) * | 1981-10-01 | 1983-05-06 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
NZ203734A (en) * | 1982-03-31 | 1986-03-14 | Beecham Group Plc | Beta-lactam derivatives and pharmaceutical compositions |
JPS60174787A (ja) | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | 3位置換カルバセフエム化合物 |
GB8409986D0 (en) * | 1984-04-17 | 1984-05-31 | Beecham Group Plc | Beta-lactam antibacterial agents |
PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
JPH0653739B2 (ja) * | 1984-11-15 | 1994-07-20 | 協和醗酵工業株式会社 | 3位置換カルバセフエム化合物 |
DE3508258A1 (de) * | 1985-03-08 | 1986-09-18 | Bayer Ag, 5090 Leverkusen | Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln |
DE3509618A1 (de) * | 1985-03-16 | 1986-09-18 | Bayer Ag, 5090 Leverkusen | Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel |
DE3689762T2 (de) * | 1985-12-13 | 1994-08-18 | Takeda Chemical Industries Ltd | Antibakterielle Verbindungen, ihre Herstellung und Verwendung. |
-
1988
- 1988-02-03 DE DE3803169A patent/DE3803169A1/de not_active Withdrawn
-
1989
- 1989-01-06 AU AU27763/89A patent/AU616453B2/en not_active Expired - Fee Related
- 1989-01-23 AT AT89101079T patent/ATE80629T1/de not_active IP Right Cessation
- 1989-01-23 DE DE8989101079T patent/DE58902264D1/de not_active Expired - Lifetime
- 1989-01-23 EP EP89101079A patent/EP0326887B1/de not_active Expired - Lifetime
- 1989-01-23 NO NO89890287A patent/NO890287L/no unknown
- 1989-01-31 IL IL89126A patent/IL89126A0/xx unknown
- 1989-02-01 PT PT89582A patent/PT89582B/pt active IP Right Grant
- 1989-02-01 CA CA000589757A patent/CA1329198C/en not_active Expired - Fee Related
- 1989-02-01 FI FI890482A patent/FI890482A/fi not_active Application Discontinuation
- 1989-02-01 JP JP1020928A patent/JPH021488A/ja active Pending
- 1989-02-01 DD DD89325418A patent/DD283329A5/de not_active IP Right Cessation
- 1989-02-01 US US07/305,317 patent/US4980348A/en not_active Expired - Fee Related
- 1989-02-02 ZA ZA89811A patent/ZA89811B/xx unknown
- 1989-02-02 HU HU89523A patent/HU204825B/hu unknown
- 1989-02-02 DK DK048489A patent/DK48489A/da not_active Application Discontinuation
- 1989-02-02 KR KR1019890001199A patent/KR890013055A/ko not_active Application Discontinuation
- 1989-02-03 CN CN89100625A patent/CN1035511A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
DE58902264D1 (de) | 1992-10-22 |
DD283329A5 (de) | 1990-10-10 |
KR890013055A (ko) | 1989-09-21 |
HUT49886A (en) | 1989-11-28 |
ZA89811B (en) | 1989-10-25 |
US4980348A (en) | 1990-12-25 |
NO890287L (no) | 1989-08-04 |
FI890482A0 (fi) | 1989-02-01 |
IL89126A0 (en) | 1989-08-15 |
DE3803169A1 (de) | 1989-08-17 |
CN1035511A (zh) | 1989-09-13 |
NO890287D0 (no) | 1989-01-23 |
JPH021488A (ja) | 1990-01-05 |
AU2776389A (en) | 1989-08-03 |
CA1329198C (en) | 1994-05-03 |
ATE80629T1 (de) | 1992-10-15 |
PT89582B (pt) | 1994-01-31 |
FI890482A (fi) | 1989-08-04 |
HU204825B (en) | 1992-05-28 |
DK48489A (da) | 1989-08-04 |
EP0326887B1 (de) | 1992-09-16 |
EP0326887A1 (de) | 1989-08-09 |
AU616453B2 (en) | 1991-10-31 |
PT89582A (pt) | 1989-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI883249A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
DK0387821T3 (da) | 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed | |
NO890657D0 (no) | Cefalosporinderivater og fremgangsmaate for deres fremstilling. | |
DK408083D0 (da) | Isoquinilinderivater, deres fremstilling og anvendelse | |
NO902607L (no) | Krystallinske cefem-syreaddisjonssalter og fremgangsmaate for fremstilling derav. | |
DK48489A (da) | Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
DK34087D0 (da) | Acyltripeptid-forbindelser og deres anvendelse som immunostimulanter | |
DK118386D0 (da) | Beta-lactam-antibiotika, deres fremstilling og anvendelse som laegemidler | |
DK222588A (da) | 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler | |
DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
DK47988D0 (da) | Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter | |
DK536986D0 (da) | Cephalosporinderivater, deres fremstilling og anvendelse | |
NO172120C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler | |
DK0390099T3 (da) | Polære cephalosporinderivater og fremgangsmåde til deres fremstilling | |
NO901418L (no) | Cefalosporinderivater og deres fremstilling. | |
ES2039255T3 (es) | Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |